PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein.
Nat Commun
; 10(1): 2484, 2019 06 06.
Article
in En
| MEDLINE
| ID: mdl-31171773
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Protein Tyrosine Phosphatases
/
Carcinoma, Hepatocellular
/
Hepatocytes
/
Cytophagocytosis
/
Tumor Microenvironment
/
Antineoplastic Agents, Immunological
/
Liver Neoplasms
/
Antibody-Dependent Cell Cytotoxicity
/
Neoplasm Proteins
Limits:
Animals
/
Humans
Language:
En
Journal:
Nat Commun
Journal subject:
BIOLOGIA
/
CIENCIA
Year:
2019
Type:
Article
Affiliation country:
Singapore